BTTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BTTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Better Therapeutics's retained earnings for the quarter that ended in Sep. 2023 was $-134.31 Mil.
Better Therapeutics's quarterly retained earnings declined from Mar. 2023 ($-120.86 Mil) to Jun. 2023 ($-128.45 Mil) and declined from Jun. 2023 ($-128.45 Mil) to Sep. 2023 ($-134.31 Mil).
Better Therapeutics's annual retained earnings declined from Dec. 2020 ($-31.41 Mil) to Dec. 2021 ($-71.74 Mil) and declined from Dec. 2021 ($-71.74 Mil) to Dec. 2022 ($-111.50 Mil).
The historical data trend for Better Therapeutics's Retained Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Better Therapeutics Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
Retained Earnings | -25.02 | -31.41 | -71.74 | -111.50 |
Better Therapeutics Quarterly Data | ||||||||||||||
Dec19 | Jun20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Retained Earnings | Get a 7-Day Free Trial | -102.74 | -111.50 | -120.86 | -128.45 | -134.31 |
Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.
Of course, if a company loses, it is called retained losses, or accumulated losses.
Better Therapeutics (OTCPK:BTTX) Retained Earnings Explanation
Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.
For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.
If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.
Of course, many companies with negative retained earnings have indeed lost money in the past.
Retained Earnings: Warren Buffett's Secret.
One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.
If the company loses more than it has accumulated, retained earnings is negative.
If a company isn't adding to its retained earnings, it isn't growing its net worth.
Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.
Microsoft is negative because it chose to buyback stock and pay dividends.
The more earnings retained, the faster it grows and increases growth rate for future earnings.
Elder Granger | director | 5176 S. LEWISTON WAY, CENTENNIAL CO 80015 |
Mark A. Berman | officer: Chief Medical Officer | 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
Geoffrey M. Parker | director | 15 RIORDAN PLACE, MENLO PARK CA 94025 |
Frank Karbe | director, officer: See Remarks | C/O MYOVANT SCIENCES INC., 2000 SIERRA POINT PARKWAY, 9TH FLOOR, BRISBANE CA 94005 |
David P Perry | director, 10 percent owner, officer: See Remarks | 1020 EAST MEADOW CIRCLE, PALO ALTO CA 94303 |
Andrew J. Armanino | director | C/O CALIFORNIA BANCORP, 1300 CLAY STREET, FIFTH FLOOR, OAKLAND CA 94612 |
Georgianna Maule-ffinch 2015 Trust | 10 percent owner | C/O BETTER THERAPEUTICS, INC., 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
Mark Heinen | officer: See Remarks | 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
Risa J Lavizzo-mourey | director | GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 60661 |
Kevin J Appelbaum | director, 10 percent owner, officer: Chief Executive Officer | 4160 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568 |
Suying Liu | director | 311 WEST 43RD STREET, 12TH FLOOR, NEW YORK NY 10036 |
Justin Zamirowski | officer: Chief Commercial Officer | 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
Kristin Wynholds | officer: Chief Product Officer | 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
Richard H Carmona | director | 1221 BROADWAY, OAKLAND CA 94612 |
David P. Perry 2015 Trust | 10 percent owner | 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
From GuruFocus
By Business Wire • 10-05-2023
By Business Wire Business Wire • 12-02-2022
By PRNewswire • 10-17-2023
By Business Wire • 07-10-2023
By Business Wire • 11-08-2023
By Business Wire Business Wire • 03-23-2023
By PRNewswire PRNewswire • 07-13-2022
By PRNewswire • 07-11-2023
By Business Wire Business Wire • 02-09-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.